Pharmaceutical companies typically use a variety of factors to determine the price of their drugs, including: Development and production costs: Pharmaceutical companies invest significant amounts of money into the research, development, and production of new drugs. The cost of these activities, including clinical trials and obtaining regulatory approval, is factored into the price of the drug. Marketing and Distribution Cost: Marketing and distribution costs may also be considered by pharmaceutical companies when determining drug prices. These costs include expenses related to advertising, sales representatives, and distribution networks. Drug Uniqueness: If a drug is the first of its kind or represents a significant improvement over existing treatments, the pharmaceutical company may set a higher price for it. If a drug has many competitors or is like existing treatments, the company may have to set a lower price to remain competitive. Market demand: Companies also consider the dem
Schedules: Schedule A, Schedule B, Schedule C, Schedule D, Schedule E1, Schedule F, Schedule G, Schedule H, Schedule H1, Schedule I, Schedule J, Schedule K, Schedule L1, Schedule M, Schedule M1, Schedule M2, Schedule M3, Schedule N, Schedule O, Schedule P, Schedule Q, Schedule R, Schedule S, Schedule T, Schedule U, Schedule V, Schedule W, Schedule X, Schedule Y
Schedule D (Rule 43) is related to import of drugs into India. Schedule D provides information about extent and condition of exemption for a class of drug in case of import.
Schedule D(I)(Rule 21D and 24A): Information and undertaking required to be submitted by the manufacturer or his authorized agent with the Application Form for a Registration Certificate. The format shall be properly filled in for each application in Form 40.
The detailed information, secret in nature, may be furnished on a Computer Floppy.
Schedule D(II) (Rule 21D and 24A): Information required to be submitted by the manufacturer or his authorized agent with the Application Form for the registration of a bulk drug/formulation/special product for its import into India.
The format shall be properly filled in and the detailed information, secret in nature, may be furnished on a Computer Floppy.
Annexure A: Information to be Submitted In Schedule D-II: Specific information required for the Blood Product
Annexure B: Information to be submitted in schedule D-II: specific information required for the diagnostic kits
Annexure C: Information to be submitted in schedule D-II: Specific information required for the vaccines
Schedule D(III)(Rule 129A): Information and undertaking required to be submitied by the manufacturer or his authorised importer/distributor/agent with the application form for a registration certificate.
For more detail refer Drug and Cosmetic Act
Schedule D (Rule 43) is related to import of drugs into India. Schedule D provides information about extent and condition of exemption for a class of drug in case of import.
Schedule D(I)(Rule 21D and 24A): Information and undertaking required to be submitted by the manufacturer or his authorized agent with the Application Form for a Registration Certificate. The format shall be properly filled in for each application in Form 40.
The detailed information, secret in nature, may be furnished on a Computer Floppy.
Schedule D(II) (Rule 21D and 24A): Information required to be submitted by the manufacturer or his authorized agent with the Application Form for the registration of a bulk drug/formulation/special product for its import into India.
The format shall be properly filled in and the detailed information, secret in nature, may be furnished on a Computer Floppy.
Annexure A: Information to be Submitted In Schedule D-II: Specific information required for the Blood Product
Annexure B: Information to be submitted in schedule D-II: specific information required for the diagnostic kits
Annexure C: Information to be submitted in schedule D-II: Specific information required for the vaccines
Schedule D(III)(Rule 129A): Information and undertaking required to be submitied by the manufacturer or his authorised importer/distributor/agent with the application form for a registration certificate.
For more detail refer Drug and Cosmetic Act
Comments
Post a Comment